In the last trading session, 0.23 million shares of the Bolt Biotherapeutics Inc (NASDAQ:BOLT) were traded, and its beta was 0.94. Most recently the company’s share price was $0.32, and it changed around $0.0 or -0.92% from the last close, which brings the market valuation of the company to $12.35M. BOLT currently trades at a discount to its 52-week high of $0.81, offering almost -153.13% off that amount. The share price’s 52-week low was $0.29, which indicates that the current value has risen by an impressive 9.38% since then.
Bolt Biotherapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.60. If we narrow it down even further, the data shows that 0 out of 5 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 4 recommended BOLT as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Bolt Biotherapeutics Inc (NASDAQ:BOLT) trade information
Instantly BOLT has showed a red trend with a performance of -0.92% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4624 on recent trading dayincreased the stock’s daily price by 30.8%. The company’s shares are currently down -39.82% year-to-date, but still up 9.90% over the last five days. On the other hand, Bolt Biotherapeutics Inc (NASDAQ:BOLT) is -17.22% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $1, which translates to bulls needing to increase their stock price by 68.0% from its current value. Analyst projections state that BOLT is forecast to be at a low of $1 and a high of $1.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -13.73%. Bolt Biotherapeutics Inc earnings are expected to increase by 24.73% in 2025, but the outlook is positive 24.06% per year for the next five years.
BOLT Dividends
Bolt Biotherapeutics Inc’s next quarterly earnings report is expected to be released in June.
VIVO CAPITAL, LLC, with 9.2354% or 3.52 million shares worth $2.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 861.87 shares worth $0.28 million, making up 2.25% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 205.54 shares worth around $66182.0, which represents about 0.54% of the total shares outstanding.
